Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharmacol Exp Ther ; 375(3): 439-450, 2020 12.
Article in English | MEDLINE | ID: mdl-33033169

ABSTRACT

Current management of metabolic acidosis in patients with chronic kidney disease (CKD) relies on dietary intervention to reduce daily endogenous acid production or neutralization of retained acid with oral alkali (sodium bicarbonate, sodium citrate). Veverimer is being developed as a novel oral treatment for metabolic acidosis through removal of intestinal acid, resulting in an increase in serum bicarbonate. Veverimer is a free-amine polymer that combines high capacity and selectivity to bind and remove hydrochloric acid (HCl) from the gastrointestinal (GI) tract. In vitro studies demonstrated that veverimer had a binding capacity of 10.7 ± 0.4 mmol HCl per gram of polymer with significant binding capacity (>5 mmol/g) across the range of pH values found in the human GI tract (1.5-7). Upon protonation, veverimer bound chloride with high specificity but showed little or no binding of phosphate, citrate, or taurocholate (<1.5 mmol/g), which are all anions commonly found in the human GI tract. Administration of veverimer to rats with adenine-induced CKD and metabolic acidosis resulted in a significant increase in fecal chloride excretion and a dose-dependent increase in serum bicarbonate to within the normal range compared with untreated controls. Absorption, distribution, metabolism, and excretion studies in rats and dogs dosed with 14C-labeled veverimer showed that the polymer was not absorbed from the GI tract and was quantitatively eliminated in the feces. Acid removal by veverimer, an orally administered, nonabsorbed polymer, may provide a potential new treatment for metabolic acidosis in patients with CKD. SIGNIFICANCE STATEMENT: Metabolic acidosis is a complication of chronic kidney disease (CKD) as well as a cause of CKD progression. Veverimer is a high-capacity, selective, nonabsorbed, hydrochloric acid-binding polymer being developed as a treatment for metabolic acidosis. Veverimer binds and removes hydrochloric acid from the gastrointestinal tract, resulting in increased serum bicarbonate and the correction of metabolic acidosis. Veverimer is not an ion-exchange resin and does not deliver sodium or other counterions, and so it may be appropriate for patients with CKD with and without sodium-sensitive comorbidities.


Subject(s)
Acidosis/complications , Acidosis/drug therapy , Hydrochloric Acid/metabolism , Polymers/administration & dosage , Polymers/pharmacology , Renal Insufficiency, Chronic/complications , Acidosis/metabolism , Administration, Oral , Animals , Biological Availability , Hydrogen-Ion Concentration , Male , Polymers/chemistry , Polymers/pharmacokinetics , Rats , Rats, Sprague-Dawley , Solubility
2.
Nat Commun ; 6: 6052, 2015 Jan 14.
Article in English | MEDLINE | ID: mdl-25586861

ABSTRACT

Polyelectrolyte complexes present new opportunities for self-assembled soft matter. Factors determining whether the phase of the complex is solid or liquid remain unclear. Ionic polypeptides enable examination of the effects of stereochemistry on complex formation. Here we demonstrate that chirality determines the state of polyelectrolyte complexes, formed from mixing dilute solutions of oppositely charged polypeptides, via a combination of electrostatic and hydrogen-bonding interactions. Fluid complexes occur when at least one of the polypeptides in the mixture is racemic, which disrupts backbone hydrogen-bonding networks. Pairs of purely chiral polypeptides, of any sense, form compact, fibrillar solids with a ß-sheet structure. Analogous behaviour occurs in micelles formed from polypeptide block copolymers with polyethylene oxide, where assembly into aggregates with either solid or fluid cores, and eventually into ordered phases at high concentrations, is possible. Chirality is an exploitable tool for manipulating material properties in polyelectrolyte complexation.


Subject(s)
Peptides/chemistry , Polymers/chemistry , Hydrogen Bonding , Protein Structure, Secondary , Stereoisomerism
3.
mBio ; 5(5): e01361-14, 2014 Sep 23.
Article in English | MEDLINE | ID: mdl-25249279

ABSTRACT

UNLABELLED: We analyzed the 16S rRNA amplicon composition in fecal samples of selected patients during their prolonged stay in an intensive care unit (ICU) and observed the emergence of ultra-low-diversity communities (1 to 4 bacterial taxa) in 30% of the patients. Bacteria associated with the genera Enterococcus and Staphylococcus and the family Enterobacteriaceae comprised the majority of these communities. The composition of cultured species from stool samples correlated to the 16S rRNA analysis and additionally revealed the emergence of Candida albicans and Candida glabrata in ~75% of cases. Four of 14 ICU patients harbored 2-member pathogen communities consisting of one Candida taxon and one bacterial taxon. Bacterial members displayed a high degree of resistance to multiple antibiotics. The virulence potential of the 2-member communities was examined in C. elegans during nutrient deprivation and exposure to opioids in order to mimic local conditions in the gut during critical illness. Under conditions of nutrient deprivation, the bacterial members attenuated the virulence of fungal members, leading to a "commensal lifestyle." However, exposure to opioids led to a breakdown in this commensalism in 2 of the ultra-low-diversity communities. Application of a novel antivirulence agent (phosphate-polyethylene glycol [Pi-PEG]) that creates local phosphate abundance prevented opioid-induced virulence among these pathogen communities, thus rescuing the commensal lifestyle. To conclude, the gut microflora in critically ill patients can consist of ultra-low-diversity communities of multidrug-resistant pathogenic microbes. Local environmental conditions in gut may direct pathogen communities to adapt to either a commensal style or a pathogenic style. IMPORTANCE: During critical illness, the normal gut microbiota becomes disrupted in response to host physiologic stress and antibiotic treatment. Here we demonstrate that the community structure of the gut microbiota during prolonged critical illness is dramatically changed such that in many cases only two-member pathogen communities remain. Most of these ultra-low-membership communities display low virulence when grouped together (i.e., a commensal lifestyle); individually, however, they can express highly harmful behaviors (i.e., a pathogenic lifestyle). The commensal lifestyle of the whole community can be shifted to a pathogenic one in response to host factors such as opioids that are released during physiologic stress and critical illness. This shift can be prevented by using compounds such as Pi-PEG15-20 that interrupt bacterial virulence expression. Taking the data together, this report characterizes the plasticity seen with respect to the choice between a commensal lifestyle and a pathogenic lifestyle among ultra-low-diversity pathogen communities that predominate in the gut during critical illness and offers novel strategies for prevention of sepsis.


Subject(s)
Critical Illness , Gastrointestinal Tract/microbiology , Microbiota , Animals , Anti-Bacterial Agents/therapeutic use , Caenorhabditis elegans/microbiology , Candida albicans/classification , Candida albicans/drug effects , Candida albicans/isolation & purification , Drug Resistance, Bacterial , Drug Resistance, Fungal , Enterobacteriaceae/classification , Enterobacteriaceae/drug effects , Enterobacteriaceae/isolation & purification , Enterococcus/classification , Enterococcus/drug effects , Enterococcus/isolation & purification , Feces/microbiology , Gene Expression Profiling , Humans , Intensive Care Units , RNA, Ribosomal, 16S/genetics , Sepsis/microbiology , Sepsis/prevention & control , Staphylococcus/classification , Staphylococcus/drug effects , Staphylococcus/isolation & purification , Virulence Factors/metabolism
4.
Antimicrob Agents Chemother ; 58(2): 966-77, 2014.
Article in English | MEDLINE | ID: mdl-24277029

ABSTRACT

Antibiotic resistance among highly pathogenic strains of bacteria and fungi is a growing concern in the face of the ability to sustain life during critical illness with advancing medical interventions. The longer patients remain critically ill, the more likely they are to become colonized by multidrug-resistant (MDR) pathogens. The human gastrointestinal tract is the primary site of colonization of many MDR pathogens and is a major source of life-threatening infections due to these microorganisms. Eradication measures to sterilize the gut are difficult if not impossible and carry the risk of further antibiotic resistance. Here, we present a strategy to contain rather than eliminate MDR pathogens by using an agent that interferes with the ability of colonizing pathogens to express virulence in response to host-derived and local environmental factors. The antivirulence agent is a phosphorylated triblock high-molecular-weight polymer (here termed Pi-PEG 15-20) that exploits the known properties of phosphate (Pi) and polyethylene glycol 15-20 (PEG 15-20) to suppress microbial virulence and protect the integrity of the intestinal epithelium. The compound is nonmicrobiocidal and appears to be highly effective when tested both in vitro and in vivo. Structure functional analyses suggest that the hydrophobic bis-aromatic moiety at the polymer center is of particular importance to the biological function of Pi-PEG 15-20, beyond its phosphate content. Animal studies demonstrate that Pi-PEG prevents mortality in mice inoculated with multiple highly virulent pathogenic organisms from hospitalized patients in association with preservation of the core microbiome.


Subject(s)
Bacterial Infections/prevention & control , Candidiasis/prevention & control , Cytostatic Agents/pharmacology , Intestinal Mucosa/drug effects , Polyethylene Glycols/pharmacology , Sepsis/prevention & control , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/pathogenicity , Animals , Bacterial Infections/microbiology , Bacterial Infections/mortality , Candida albicans/drug effects , Candida albicans/pathogenicity , Candidiasis/microbiology , Candidiasis/mortality , Cytostatic Agents/chemical synthesis , Drug Resistance, Multiple, Bacterial , Enterococcus faecalis/drug effects , Enterococcus faecalis/pathogenicity , Humans , Intestinal Mucosa/microbiology , Mice , Mice, Inbred C57BL , Phosphates/chemistry , Polyethylene Glycols/chemical synthesis , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/pathogenicity , Sepsis/microbiology , Survival Analysis , Virulence
5.
ACS Macro Lett ; 1(11): 1228-1232, 2012 Nov 20.
Article in English | MEDLINE | ID: mdl-35607146

ABSTRACT

Recently, polyesters based on the diol monomer 2,2,4,4-tetramethyl-1,3-cyclobutanediol (TMCBDO) have been shown to exhibit excellent thermal stability, mechanical properties, and optical clarity. In particular, the ability of TMCBDO to replace bisphenol A as a diol monomer in polycarbonates and polyesters has resulted in significant commercial and academic interest in these types of monomers. Herein, we report a versatile synthetic strategy based on the dimerization of ketenes derived from the thermal treatment of Meldrum's acid for the synthesis of structurally diverse cyclobutanediol (CBDO) monomers. This strategy allows a library of CBDO monomers amenable to standard polyester polymerization procedures to be prepared and the structural diversity of these CBDO monomers provides polymers with tunable physical properties, such as glass transition temperature ranging from 120 to 230 °C. The versatility and modularity of this Meldrum's acid-based approach to substituted cyclobutanediols, combined with the ease of synthesis, will be important for the further development of high-performance polyester materials that are not based on bisphenol A.

6.
J Polym Sci A Polym Chem ; 49(20): 4498-4504, 2011 Oct 15.
Article in English | MEDLINE | ID: mdl-21966093

ABSTRACT

Allyl glycidyl ether, polymerized from potassium alkoxide/naphthalenide initiators under both neat and solution conditions was shown to be a highly-controlled process. In both cases, molar masses (10-100 kg/mol) were determined by the reaction stoichiometry, and low polydispersity indices (1.05-1.33) could be obtained with a full understanding of the dominant side reaction, isomerization of the allyl side chain, being developed. The degree of isomerization of allyl to cis-prop-1-enyl ether groups (0 - 10 % mol.) was not correlated to the molar mass or polydispersity of the polymer but was dictated by the polymerization temperature. This allows the extent of isomerization to be reduced to essentially zero under either melt or solution conditions at polymerization temperatures of less than 40 °C.

7.
Chem Commun (Camb) ; 47(38): 10572-4, 2011 Oct 14.
Article in English | MEDLINE | ID: mdl-21879045

ABSTRACT

A facile, ketene-based strategy for the synthesis of polyesters from stable Meldrum's acid monomers has been developed which overcomes many issues associated with traditional step-growth procedures. A significant increase in polymerization efficiency is observed with only 10 min reaction time at 220 °C being needed to obtain high molecular weight polymers.


Subject(s)
Ethylenes/chemistry , Ketones/chemistry , Polyesters/chemistry , Dioxanes/chemistry , Molecular Weight , Polyesters/chemical synthesis , Temperature , Thermodynamics
SELECTION OF CITATIONS
SEARCH DETAIL
...